Data / Research funding / Interstitial Cystitis
Interstitial Cystitis: 85 NIH awards ($98.7M) to 45 organizations
85 NIH awards ($98.7M) in the NIH spending category Interstitial Cystitis, to 45 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
85 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| PNPase inhibition as an effective treatment for chronic bladder pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,942,335 | September 24, 2022 | August 31, 2027 | BIRDER, LORI A | reporter.nih.gov |
| A BRIEF, TRANSDIAGNOSTIC COGNITIVE BEHAVIORAL TREATMENT FOR UROLOGIC CHRONIC PELVIC PAIN SYNDROME (UCPPS): PROCESS, PREDICTIONS, OUTCOMES | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,263,376 | September 21, 2021 | July 31, 2027 | LACKNER, JEFFREY M | reporter.nih.gov |
| An integrated exercise and bladder training intervention to reduce falls in older women with urinary incontinence | NIH | National Institute on Aging | 2021 to 2025 | $3,172,146 | September 30, 2021 | August 31, 2026 | ANDY, UDUAK UMOH | reporter.nih.gov |
| CNS Mechanisms of IC/BPS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,109,471 | August 1, 2018 | March 31, 2027 | GEREAU, ROBERT W | reporter.nih.gov |
| Targeting Interindividual Variability in NSAID Responses to Mitigate Chronic Pelvic Pain Risk in Dysmenorrhea | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $3,077,376 | September 17, 2024 | August 31, 2027 | HELLMAN, KEVIN | reporter.nih.gov |
| MECHANISMS OF AGE-and SEX- DEPENDENT CHANGES IN URINARY BLADDER IMMUNITY | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,005,541 | September 15, 2025 | August 31, 2029 | MYSOREKAR, INDIRA U | reporter.nih.gov |
| Signal integration by specialized mesenchyme in urothelial homeostasis and Interstitial Cystitis / Bladder Pain Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,991,425 | September 24, 2022 | August 31, 2027 | BEACHY, PHILIP A | reporter.nih.gov |
| Metabolomic Signatures of Urologic Chronic Pelvic Pain Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,812,460 | July 15, 2021 | April 30, 2027 | HENDERSON, JEFFREY P | reporter.nih.gov |
| UroEDIC Bladder: Bladder Dysfunction in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,536,849 | June 1, 2021 | March 31, 2026 | SARMA, ARUNA V | reporter.nih.gov |
| High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,415,000 | September 30, 2021 | July 31, 2027 | WESSELY, OLIVER | reporter.nih.gov |
| Impact of Amygdala Lateralization on Processing and Modulation of Bladder Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,294,587 | August 1, 2018 | August 31, 2028 | KOLBER, BENEDICT J | reporter.nih.gov |
| Neural Mechanisms Underlying IC/BPS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,281,071 | May 5, 2021 | February 28, 2027 | SAMINENI, VIJAY K | reporter.nih.gov |
| Mechanistic-Based Treatment of Interstitial Cystitis/Bladder Pain Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,193,826 | May 5, 2023 | February 29, 2028 | MCKERNAN, LINDSEY COLMAN | reporter.nih.gov |
| Role of neuron-satellite glia cell signaling in pelvic pain and visceral cross-sensitization | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,081,882 | September 20, 2023 | July 31, 2028 | SUADICANI, SYLVIA OTTILIE | reporter.nih.gov |
| Role of Urothelial Purinergic Signaling in Diabetic Bladder Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,061,868 | January 9, 2020 | September 14, 2028 | MUTAFOVA-YAMBOLIEVA, VIOLETA N. | reporter.nih.gov |
| Motor cortical neuromodulation in women with Interstitial Cystitis/Bladder Pain Syndrome: reducing pain by improving brain and muscle activity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,060,111 | August 15, 2020 | April 30, 2026 | KUTCH, JASON J. | reporter.nih.gov |
| Cystitis-induced bladder dysfunction and pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,050,607 | January 28, 2021 | December 31, 2025 | VIZZARD, MARGARET ANN | reporter.nih.gov |
| Cross Organ Mechanisms in Chronic Pelvic Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,992,227 | May 15, 2023 | March 31, 2028 | TU, FRANK FU-SHENG | reporter.nih.gov |
| Stress and Anxiety Effects on Overactive Bladder: A Controlled Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,973,971 | September 15, 2021 | July 31, 2027 | SEBESTA, ELISABETH M | reporter.nih.gov |
| Neuroimmune Interface in Urological Chronic Pelvic Pain Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,945,113 | January 22, 2020 | November 30, 2025 | HARTE, STEVEN EDWARD | reporter.nih.gov |
| TLR Transduction of Dysbiotic Pelvic Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,838,981 | August 21, 2023 | June 30, 2027 | KLUMPP, DAVID J | reporter.nih.gov |
| Sleep and Bladder Study | NIH | National Institute on Aging | 2022 to 2025 | $1,828,940 | August 1, 2022 | January 31, 2027 | TYAGI, SHACHI | reporter.nih.gov |
| Novel Mechanistic Approaches in Prevention, Treatment and Non-Invasive Assessment of Radiation Cystitis in Mice | NIH | National Cancer Institute | 2021 to 2024 | $1,753,498 | June 1, 2021 | May 31, 2026 | KANAI, ANTHONY JOHN | reporter.nih.gov |
| Early life bladder inflammatory events in female mice lead to subsequent LUTS in adulthood | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,726,803 | May 1, 2023 | February 28, 2027 | ZDERIC, STEPHEN ANTHONY | reporter.nih.gov |
| Activating Peripheral Glia to Relieve Visceral Pain in Animal Models of Urological Chronic Pelvic Pain Syndrome (UCPPS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,682,164 | July 19, 2021 | May 31, 2026 | XIE, XIAOQIAO | reporter.nih.gov |
| Effect of neonatal and adult stress on pelvic pain disorders and comorbidity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,565,879 | August 25, 2014 | February 28, 2026 | CARLSTEN CHRISTIANSON, JULIE A | reporter.nih.gov |
| Quantitative Studies in Urinary Bladder Sensation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,532,520 | July 25, 1997 | August 31, 2026 | NESS, TIMOTHY J | reporter.nih.gov |
| Molecular and cellular mechanisms of visceral pain and cross-organ sensitization | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,461,766 | August 20, 2024 | June 30, 2029 | KIM, BRIAN | reporter.nih.gov |
| Contribution of Stress Induced Autonomic and Urothelial Dysregulation to IC/BPS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,375,978 | August 20, 2018 | September 30, 2025 | BIRDER, LORI A | reporter.nih.gov |
| Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Based Bladder Permeability Assay | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,353,098 | September 20, 2015 | May 31, 2025 | KAUFMAN, JONATHAN H | reporter.nih.gov |
| The role of amphiregulin in mediating radiation cystitis in cancer survivors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,337,343 | April 15, 2023 | February 29, 2028 | ZWAANS, BERNADETTE MARGARETHA MARIA | reporter.nih.gov |
| Spinal Mechanisms Underlying Interstitial Cystitis/Bladder Pain Syndromes (IC/BPS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,314,849 | June 10, 2024 | April 30, 2029 | SAMINENI, VIJAY K | reporter.nih.gov |
| Preclinical phenotypic modeling of chronic urologic pelvic pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,288,473 | April 1, 2022 | March 31, 2027 | DEBERRY, JENNIFER J | reporter.nih.gov |
| SuperGAGs for Intravesicular Treatment of Interstitial Cystitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1,266,580 | June 1, 2018 | June 30, 2023 | HURST, ROBERT EVAN | reporter.nih.gov |
| Elucidating Roles of Distinct Spinal Cord Cell types in Mediating Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,243,356 | August 20, 2024 | June 30, 2029 | SAMINENI, VIJAY K | reporter.nih.gov |
| Characterization of Hypogastric Afferent Pathway Involved in Urinary Bladder Function and Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,176,600 | September 1, 2023 | June 30, 2027 | BECKEL, JONATHAN M | reporter.nih.gov |
| Targeting angiotensin and inflammation to prevent radiotherapy-induced bladder toxicity. | NIH | National Cancer Institute | 2024 to 2025 | $1,100,715 | August 1, 2024 | July 31, 2029 | MARPLES, BRIAN | reporter.nih.gov |
| Urothelial Cells and Sensory Signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,094,716 | September 1, 2024 | August 31, 2029 | MICKLE, AARON DAVID | reporter.nih.gov |
| Cav1.2 in bladder physiology and pathology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,067,456 | March 21, 2024 | January 31, 2028 | YU, WEIQUN | reporter.nih.gov |
| A randomized, sham-controlled clinical trial evaluating individualized neuromodulation of cortical regions involved in neurogenic overactive bladder in Multiple Sclerosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,039,129 | January 24, 2023 | December 31, 2027 | KHAVARI, ROSE | reporter.nih.gov |
| Pannexin 1 channels, new players in diabetic bladder dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $964,586 | September 3, 2019 | June 30, 2025 | SUADICANI, SYLVIA OTTILIE | reporter.nih.gov |
| Investigation of Non-Invasive Pulsed Electromagnetic Field (PEMF) Therapy for Female Patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $917,600 | April 1, 2022 | March 31, 2026 | WALKER, STEPHEN | reporter.nih.gov |
| PACAP/PAC1 receptor signaling in micturition neurocircuits: effects of stress and injury/inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $906,920 | September 15, 2023 | June 30, 2026 | VIZZARD, MARGARET ANN | reporter.nih.gov |
| RELIEPH for Interstitial Cystitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $769,386 | July 1, 2018 | March 31, 2024 | XU, YAN | reporter.nih.gov |
| Serotonin signaling in control of the Lower Urinary Tract | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $764,999 | February 1, 2019 | May 31, 2024 | SOUTHARD-SMITH, E MICHELLE | reporter.nih.gov |
| Underlying mechanisms controlling urothelial ATP release and their contributions to urinary bladder physiology and pathophysiology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $704,250 | August 20, 2018 | May 31, 2024 | BECKEL, JONATHAN M | reporter.nih.gov |
| Food-specific antibodies and urologic chronic pelvic pain syndrome. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $695,081 | September 15, 2022 | August 31, 2025 | SUTCLIFFE, SIOBHAN | reporter.nih.gov |
| Structural and functional mapping of visceral pain afferent neurocircuitries of the colorectum and bladder in preclinical models | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $694,804 | September 19, 2019 | August 31, 2024 | MULUGETA, MILLION | reporter.nih.gov |
| Role of fibroblasts in bladder mucosal function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $690,451 | January 10, 2025 | December 31, 2028 | CARATTINO, MARCELO DANIEL | reporter.nih.gov |
| Mechanisms of neurogenic bladder dysfunction in a viral murine model of multiple sclerosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $684,200 | September 8, 2020 | October 31, 2024 | MALYKHINA, ANNA P | reporter.nih.gov |
| Direct conversion of fibroblasts to urothelial stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $669,804 | August 1, 2022 | April 30, 2027 | PRADO, KRIS | reporter.nih.gov |
| A multi-centric randomized trial of daily nitrofurantoin versus bladder fulguration plus daily nitrofurantoin for the long-term management of cystitis in women with recurrent urinary tract infections | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $653,123 | September 1, 2025 | June 30, 2030 | ZIMMERN, PHILIPPE E | reporter.nih.gov |
| High-Density Surface Electromyography Guided Precision Botulinum Neurotoxin Injections to Manage Chronic Pelvic Floor Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $614,859 | August 15, 2022 | June 30, 2024 | ZHANG, YINGCHUN | reporter.nih.gov |
| Role of Angiotensin II in Bladder Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $584,309 | September 21, 2022 | August 31, 2024 | MICKLE, AARON DAVID | reporter.nih.gov |
| Role of Angiotensin II in Bladder Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $572,700 | September 21, 2022 | August 31, 2027 | MICKLE, AARON DAVID | reporter.nih.gov |
| Neuromolecular Mechanisms of Chronic Pelvic Pain in Neonatally-induced Cystitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $560,466 | August 5, 2014 | May 31, 2023 | SENGUPTA, JYOTI N | reporter.nih.gov |
| Macrophage Migration Inhibitory Factor mediates bladder pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $553,100 | July 1, 2019 | December 31, 2024 | VERA, PEDRO L | reporter.nih.gov |
| The Urinary Microbiota and Host Inflammation in Lower Urinary Tract Symptoms | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $503,496 | September 1, 2019 | July 31, 2025 | ACKERMAN, A. LENORE | reporter.nih.gov |
| Novel treatment for urinary incontinence and overactive bladder symptoms in the elderly | NIH | National Institute on Aging | 2024 to 2025 | $499,892 | September 5, 2024 | May 31, 2026 | ZHANG, QIAOJUAN | reporter.nih.gov |
| Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $494,387 | May 13, 2019 | August 31, 2024 | MCKERNAN, LINDSEY COLMAN | reporter.nih.gov |
| Molecular Characterization Of A Large Cross-Sectional And Longitudinal Collection of Patients To Investigate Disease Progression in IC/BPS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $465,000 | May 1, 2020 | April 30, 2024 | WALKER, STEPHEN | reporter.nih.gov |
| Comparative effectiveness of pelvic floor muscle training, Mirabegron, and Trospium among older women with urgency urinary incontinence and high fall risk: a feasibility randomized clinical study. | NIH | National Institute on Aging | 2023 to 2024 | $426,270 | May 15, 2023 | April 30, 2026 | FISHER, STEVEN R | reporter.nih.gov |
| Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions (The MSK-PELVIC Study) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $419,450 | September 16, 2022 | August 31, 2025 | FITZGERALD, COLLEEN MARIE | reporter.nih.gov |
| The urinary microbiome and bladder toxicity after pelvic radiotherapy | NIH | National Cancer Institute | 2024 | $414,781 | August 1, 2024 | July 31, 2026 | MARPLES, BRIAN | reporter.nih.gov |
| Therapeutic Exploitation of IPSE, a Urogenital Parasite-Derived Host Modulatory Protein, for Bladder Hypersensitivity Syndromes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $396,261 | May 5, 2017 | April 30, 2024 | HSIEH, MICHAEL HARRISON | reporter.nih.gov |
| A device to treat high-tone pelvic floor dysfunction in women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $384,959 | June 1, 2023 | May 31, 2024 | BOHORQUEZ, JOSE LUIS | reporter.nih.gov |
| Targeted Temperature Modulation with Smart Radiometric Monitoring for Effective and Long-Lasting Opioid-Free Pelvic Pain Relief - A Novel Low-Cost, Portable, Tampon-sized Thermal Transfer Device. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $384,737 | September 25, 2023 | August 31, 2025 | LYON, ZACHARY W | reporter.nih.gov |
| High-Density Surface Electromyography Guided Precision Botulinum Neurotoxin Injections to Manage Chronic Pelvic Floor Pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $341,988 | June 4, 2024 | June 30, 2025 | ZHANG, YINGCHUN | reporter.nih.gov |
| Role of Vitamin D in the Prevention and Progression of Urinary Incontinence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $339,107 | April 1, 2018 | March 31, 2023 | MARKLAND, ALAYNE DENISE | reporter.nih.gov |
| PACAP/PAC1R signaling and CRH intersections in micturition circuits: effects of stress and injury/inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $320,778 | September 15, 2025 | August 31, 2028 | VIZZARD, MARGARET ANN | reporter.nih.gov |
| Assessing multifactorial etiology of IC/BPS using a novel PFM-Hip-Trunk muscle network analysis | NIH | National Institute of Nursing Research | 2022 | $247,948 | August 5, 2022 | July 31, 2024 | ZHANG, YINGCHUN | reporter.nih.gov |
| Regulation of pelvic pain and micturition reflex by VEGF in urological chronic pelvic pain syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $233,250 | August 1, 2019 | May 31, 2024 | MALYKHINA, ANNA P | reporter.nih.gov |
| DEFINING THE NEURAL BASIS FOR CHRONIC BLADDER PAIN AND ITS ASSOCIATED COMORBID DISORDERS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $232,300 | August 1, 2018 | July 31, 2023 | SAMINENI, VIJAY K | reporter.nih.gov |
| University of Michigan MAPP Research Network Discovery Site | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $222,473 | September 15, 2008 | June 30, 2023 | CLAUW, DANIEL J | reporter.nih.gov |
| The impact of amygdala CGRP receptors on the development of persistent bladder pain. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $209,964 | April 1, 2021 | March 31, 2024 | LEWTER, LAKEISHA | reporter.nih.gov |
| Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Discovery Site | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $158,249 | September 15, 2008 | June 30, 2024 | MAYER, EMERAN A | reporter.nih.gov |
| The Role of the Vaginal Microbiota in Urgency Urinary Incontinence in Older Women | NIH | National Institute on Aging | 2021 | $156,000 | September 15, 2020 | May 31, 2023 | ACKERMAN, A. LENORE | reporter.nih.gov |
| Urology Chronic Pelvic Pain Longitudinal Symptom Patterns Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $145,833 | September 15, 2008 | June 30, 2024 | KREDER, KARL J | reporter.nih.gov |
| Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Extension Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $140,000 | September 15, 2008 | June 30, 2024 | LAI, HING HUNG HENRY | reporter.nih.gov |
| Receptor-mediated dysfunction of satellite glia and uninjured sensory neurons as a novel link between referred neuropathic pain and bladder disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $111,664 | April 26, 2023 | April 25, 2026 | TRAN, EMILY L | reporter.nih.gov |
| Evaluation of the influence of angiotensin type 1 receptor expression under disease conditions in an autoimmune cystitis animal model | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $49,538 | September 5, 2025 | September 4, 2027 | ROBILOTTO, GABRIELLA | reporter.nih.gov |
| Role of hemopexin in the development of urologicchronic pelvic pain syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $40,556 | February 1, 2025 | January 31, 2027 | CAANGAY, ANASTASIIA E | reporter.nih.gov |
| Investigation of Cell-Type Specific Contributions to Bladder Pain Modulation in the Central Amygdala | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $35,280 | January 19, 2019 | September 27, 2021 | ALLEN, HEATHER NOEL | reporter.nih.gov |
| Pelvic Pain and Depression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1 | September 15, 2008 | June 30, 2023 | KLUMPP, DAVID J | reporter.nih.gov |
| WSU Urologic Chronic Pelvic Pain Syndromes Discovery Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $1 | September 15, 2008 | June 30, 2024 | BOGIC, MARIJA | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 40 | $22,421,634 | 0 | $0 |
| 2024 | 43 | $21,841,175 | 0 | $0 |
| 2023 | 41 | $17,469,546 | 0 | $0 |
| 2022 | 41 | $20,301,748 | 0 | $0 |
| 2021 | 43 | $16,650,784 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.